Lista de obras - Jaume Puig-Junoy - Dominio Público Uruguay

Authors' Reply to Angelis and Kanavos: "Does MCDA Trump CEA?"

scientific article published on 01 February 2019

Cost accounting and public reimbursement schemes in Spanish hospitals

artículo científico publicado en 2006

Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study.

artículo científico publicado en 2012

Cost efficiency in primary care contracting: a stochastic frontier cost function approach

scientific article published on 01 December 2004

Cost-utility analysis of second-generation direct-acting antivirals for hepatitis C: a systematic review

scientific article published on 31 October 2018

Critical appraisal of pharmacoeconomic studies comparing TNF-alpha antagonists for rheumatoid arthritis treatment

artículo científico publicado en 2007

De la utilidad de los medicamentos al valor terapéutico añadido y a la relación coste-efectividad incremental

Do Higher-Priced Generic Medicines Enjoy a Competitive Advantage Under Reference Pricing? ⬇️

artículo científico publicado el 1 de noviembre de 2012

Does MCDA Trump CEA?

artículo científico publicado en 2018

Does €1 Per Prescription Make a Difference? Impact of a Capped Low-Intensity Pharmaceutical Co-Payment.

artículo científico publicado en 2018

Economic evaluations of massive HPV vaccination: within-study and between study variations in incremental cost per QALY gained.

scientific article published on 14 February 2009

Free prescriptions for low-income pensioners? The cost of returning to free-of-charge drugs in the Spanish National Health Service

scientific article published on 15 September 2020

Health care financing: is it enough and appropriate?

artículo científico publicado en 2006

Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients

artículo científico publicado en 2003

Impact of European pharmaceutical price regulation on generic price competition: a review

artículo científico publicado en 2010

Incentives and pharmaceutical reimbursement reforms in Spain

artículo científico publicado en 2004

Income transfer policies and the impacts on the immunization of children: the Bolsa Família Program

artículo científico publicado en 2012

Institutional change, innovation and regulation failure: evidence from the Spanish drug market

article

Launch prices for new pharmaceuticals in the heavily regulated and subsidized Spanish market, 1995-2007.

artículo científico publicado en 2014

Measuring technical efficiency of output quality in intensive care units

scientific article published on 01 January 1997

Non-healthcare costs of hepatitis C: A systematic review.

artículo científico

Technical efficiency in the clinical management of critically ill patients ⬇️

artículo científico publicado el 1 de mayo de 1998

The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain.

artículo científico publicado en 2010

The impact of taxing sugar-sweetened beverages on cola purchasing in Catalonia: an approach to causal inference with time series cross-sectional data

artículo científico publicado en 2020

What is required to evaluate the impact of pharmaceutical reference pricing?

artículo científico publicado en 2005

What is the social cost of injured people in traffic collisions? An assessment for Catalonia.

artículo científico publicado en 2011

[Advances and experiences in economic evaluation of medicines: a complementary view]

artículo científico publicado en 2008

[Comment. Substitution at pharmacies and generic market]